Stock listing
TSX:TRIL Trillium Therapeutics Inc Stock
Follow Trillium Therapeutics Inc into a list and get an email when it puts out news.
Delisted TSX:TRIL no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- TSX:TRIL
- Asset type
- Stock
- Exchange
- TSX
- Currency
- CAD
Latest news
Trillium Therapeutics Inc on 6ix
- News releases
- 15 in all · newest Sep 14, 2017 · oldest 2006
- Decks
- 1 deck · latest Apr 28, 2021
Where Trillium Therapeutics Inc is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| TSX:TRIL · This page · Delisted | TSX | Canada | CAD |
| NASDAQ:TRIL · Delisted | NASDAQ | United States | USD |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Day (April 2021) | Investor day | 112 slides | Apr 28, 2021 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Paolo Pucci Other companies: Replimune Group, Inc. (Director · Since at least Apr 1, 2020); West Pharmaceutical Services, Inc. (Director · Since at least Sep 12, 2016); Lumos Pharma Inc (Director · Nov 12, 2015 – May 23, 2018 · Past); Dyax Corp (Director · Nov 1, 2011 – Jan 13, 2016 · Past); ArQule Inc (Chief Executive Officer, Director · Jun 9, 2008 – Jan 16, 2020 · Past) | Director · Jan 1, 2021 – Nov 17, 2021 · Past |
| Luke Beshar Other companies: Protara Therapeutics, Inc. (Chairman · Since at least Jan 9, 2020); Omega Therapeutics Inc (Director · Jul 29, 2021 – Jun 7, 2023 · Past); Regenxbio Inc. (Director · Sep 16, 2015 – Jun 4, 2021 · Past) | Director · Jan 1, 2021 – Nov 17, 2021 · Past |
| Helen Tayton-Martin Other companies: Evaxion A/S (Chief Executive Officer · Since at least Mar 18, 2026); Adaptimmune Therapeutics PLC (Chief Business & Strgy Officer · Jan 1, 2016 – Jan 15, 2024 · Past) | Director · Jan 1, 2021 – Nov 17, 2021 · Past |
| James Parsons Other companies: Oncolytics Biotech Inc. (Director · Since at least Jan 1, 2026); DiaMedica Therapeutics Inc. (Chairman of the Board · Since at least Dec 6, 2018) | Chief Financial Officer · Jan 1, 2021 – Nov 17, 2021 · Past |
| Jan Skvarka Other companies: Monte Rosa Therapeutics, Inc. (Executive Chairman, DEM Biopharma · Since at least Mar 23, 2023); Zentalis Pharmaceuticals, Inc. (Director · Since at least Sep 9, 2022) | President and CEO, Director · Jan 1, 2021 – Nov 17, 2021 · Past |
| Benjamin Looker Other companies: Esperion Therapeutics, Inc. (Chief Legal Officer · Since at least Jan 1, 2022) | General Counsel · Apr 26, 2021 – Nov 17, 2021 · Past |
| Rosemary Harrison Other companies: Tcr2 Therapeutics Inc (Chief Business & Strategy · Jan 10, 2022 – Jun 1, 2023 · Past) | See Remarks · Jan 1, 2021 – Nov 17, 2021 · Past |
| Robert Uger | Chief Scientific Officer · Jan 1, 2021 – Nov 17, 2021 · Past |
Log in to ask 6ix AI your own questions about Trillium Therapeutics Inc.